Alethea Capital Management’s Sanofi SNY Stock Holding History

Alethea Capital Management’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-18,012	Closed	-$868K	–	113
2021 Q3	$868K	Buy	+18,012	New	+$916K	0.76%	12
2021 Q2	–	Sell	-18,415	Closed	-$911K	–	107
2021 Q1	$911K	Buy	+18,415	New	+$885K	0.56%	21
2019 Q1	–	Sell	-34,957	Closed	-$1.52M	–	92
2018 Q4	$1.52M	Buy	+34,957	New	+$1.54M	2.21%	11
2017 Q4	–	Sell	-15,948	Closed	-$794K	–	103
2017 Q3	$794K	Buy	+15,948	New	+$772K	0.93%	31

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Alethea Capital Management's SNY Position: Q4 2021 in Review

Alethea Capital Management sold out of Sanofi (SNY) in Q4 2021, closing a stake of 18,012 shares — an estimated $868K sold.

Alethea Capital Management first reported a position in SNY in Q3 2017 and held it in 4 quarters. The position peaked at $1.52M in Q4 2018. 624 funds tracked by Wall St. Rank hold SNY as of Q4 2021.

Alethea Capital Management reported no remaining Sanofi position as of Q4 2021 after selling out during the quarter.
Alethea Capital Management sold 18,012 Sanofi shares in Q4 2021, an estimated $868K.
Alethea Capital Management first reported a position in Sanofi in Q3 2017 and held it in 4 quarters.
Alethea Capital Management's Sanofi position peaked at $1.52M in Q4 2018.
624 funds tracked by Wall St. Rank held Sanofi as of Q4 2021.

Based on Alethea Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.